Health Economics and Outcomes Research

The society, including governments, is constantly seeking ways to maximize health outcomes with minimal cost. By identifying and measuring the link between treatments or interventions delivered and the actual outcomes achieved, employing outcomes research, we are able to make inferences using real-world evidence.

Our health access research improves processes that contribute to health outcomes in a manner beneficial to a diverse range of people.

Here’s how:

Systematic Literature Reviews

Demonstrating Expertise and Outcomes through Comprehensive Literature Reviews

Our experts at Health Research Partners lend their epidemiological expertise to develop methods and report findings that meet the high standards of peer-reviewed journals. Depending on where you are in the process, we can assist with your team’s research strategy to help minimize potential errors or avoidable delays.

Quality control is an essential part of our methodological literature review process. Our quality control strategies help us ensure that research processes and systematic reviews are executed exactly as intended, using established peer-reviewed methodology. We are available to help with any aspect of the systematic review process, including:

  • Using highly-structured processes, by identifying, evaluating and integrating all evidence related to specific health-associated research questions
  • Conduct systematic reviews, meta-analysis, value dossiers, and cost-effectiveness analyses to support policy-making and licensing decisions
  • Utilize the expertise of a multidisciplinary team to work closely with clients to carry out evidence synthesis projects that are agile and are of high quality and rigor.

Statistical Analyses

Minimizing Uncertainty in Clinical Trials through Statistical Analyses

The primary function of statistical analyses is to control unpredictability and reach accurate inference and decision making. This is particularly crucial in clinical research, where negligent planning can rapidly harm patients and lead to unreliable research results and wasted resources.

At Health Research Partners, we place great emphasis on formalizing and applying advanced mathematical and statistical methods to determine optimal actions and reduce risks for our clients. The experience and expertise of our statistical analysts lie in innovative approaches that enable our clients to implement flexible individually tailored solutions for complex problems at the highest quality. Our biostatisticians and epidemiologists offer a range of analytical support and services. This includes:

  • Statistical consulting at every project phase
  • Risk identification and assessments
  • Supporting the planning clinical study reports
  • Providing statistical programming and development of analysis databases
  • Developing modern and innovative trial designs
  • Developing defined statistical analysis plans
  • Reviewing and analyzing data, leading to the generation of scientific statistical reports and visualization of results
  • Supporting publications and scientific presentations, including interpretation of data and results
  • Statistical reviews of relevant clinical trials, including processes and documents

Economic Evaluation

Shaping Projects around Core Foundations in Health Economic Evaluations

Economic Evaluation continues to be an important aspect of healthcare decision-making around the world. In addition to formal evaluation guidelines for assessing the cost effectiveness of prospective medicines, devices, and medical technologies in terms of health outcomes, health economic methods are increasingly being applied to healthcare and broader human service program evaluation and policy analysis.

At Health Research Partners, our team provides a comprehensive range of health economic services across traditional research and evaluation settings and into health-related human service sectors. We partner with our clients to provide an efficient range of health economic services to support complex program evaluation and management with outcome-focused evidence. Our established methods of economic evaluation include:

  • Cost Effectiveness Analysis (CEA)
  • Cost Benefit Analysis (CBA)
  • Cost Utility Analysis (CUA)
  • Data linkage
  • Predictive analytics based on machine learning
  • Health Technology Assessments
  • Burden of disease studies
  • Economic decision analysis and modeling
  • Established methods of evaluating uncertainty through sensitivity analyses
    • Biostatistics
    • Epidemiology

Evidence Generation

Developing Compelling Evidence to Demonstrate Value and Gain Market Access

Healthcare studies often require access to evidence generation to optimize value. Processing large databases and administrative datasets help to aid the conversion of data to evidence. At Health Research Partners, we leverage our large network of industry partners to access administrative claims data, electronic medical records, and other observational health data sources to design research protocols, synthesize data and information, utilize analytics and make scientific hypothesis that convert data to insights.

We offer answers to our clients’ specific research questions and disperse insights into industry literature. The objective of our outcomes research strategies is to make certain that our clients are on track to develop evidence. We demonstrate the comparative value of products and satisfy the needs of patients, payers, providers, and other health stakeholders. Our experts work with you to develop evidence to support your value proposition through services, including:

  • Retrospective data analyses
  • Prospective observational studies
  • Regulatory and measurement strategy
  • Comparative effectiveness and safety studies
  • Literature review and meta-analysis
  • Systematic reviews, scoping reviews, rapid reviews
  • Incidence, prevalence, and burden of illness
  • Health economic assessments and costing algorithms
  • Health economic models and Health Technology Assessment submissions

Real World Evidence

Helping Health stakeholders Make Important and Life-Saving Real-Time Decisions

As more countries strive to minimize healthcare costs, fix the aging population, and reduce the number of people with chronic diseases, the need to remove inefficiencies and improve health outcomes through Real World Evidence is more urgent. Real World Evidence progressively impacts the biopharmaceutical value chain, facilitating the discovery and development of drugs, aiding regulatory approvals, recommending novel ways for demonstrating value for market access, and creating innovative business models by using patient outcomes.

As a research organization, Health Research Partners can help you understand the regulatory impact on cost and outcomes for patients. We understand the necessity of bringing together diagnostics, patient information, and treatment information to illustrate the value in real world evidence.

Our team of experienced statisticians, data scientists, and epidemiologists work with real world data to show health outcomes studies, patient adherence, comparative effectiveness, population health, and epidemiology studies. We support our clients in planning strategic evidence generation and designing real-world research from very early in development, including helping them in:

  • Studying natural history
  • Historical or concurrent clinical trial controls
  • Registering and analyzing rare diseases
  • Carrying out pragmatic studies
  • Expanding access and compassionate use programs
  • Retrospective research
  • Scientific surveys

Non-Intervention Studies

Expertly Providing Comprehensive Observation and Evaluation Plans for Documenting Data

Many stakeholders in the healthcare industry are demanding more data and information in the real world. This means that non-interventional studies, that is, epidemiological studies, in which no study-related intervention is performed on the patient, are increasingly required in providing a rapid supply of information.

Using digital systems, information and data from various sources are collected and analyzed. We provide consultation with our expertise to assure the suitable design selections, planning quality, execution, evaluation, and reporting of observational trials. Depending on our client’s preferences and needs, we can take over specific aspects or the entire process of a study. For non-intervention studies, we provide you with the following services:

  • Quality Risk Management
  • Regulatory Support
  • Project Management
  • Monitoring
  • Data Management

Medical Writing

Early Identification and Interpretation of Signals through Evidenced Writing and Communication

In developing complex scientific documents or delivering supporting clinical development, medical writing covers a range of medical disciplines, registration, and marketing of pharmaceutical drugs. Our medical writers offer extensive expertise in multiple medical fields.

Our team possesses the experience, the skills and the tools for developing scientific documents, including manuals, study protocols, operational plans, journal manuscripts, promotional literature, informed consent forms, and other documents relevant to clinical development. Our medical writing services also include:

  • Professional advice on study designs and protocol development
  • Development of study concepts, trial protocols and observational plans
  • Safety narratives
  • Preparation of clinical study reports
  • Consulting

How can we be of help?

Want to learn more about how we can help you optimize your research?